You are here

Astellas

AACR 2022 – A weekend of updates yields few winners

EP Vantage

Tue, 04/12/22 - 10:34 am

Bicycle Therapeutics

Rubius Therapeutics

C4 Therapeutics

Astellas' menopause drug suffers rare setback as failed Asian trial blots previously pristine record

Fierce Biotech

Tue, 03/15/22 - 10:41 am

clinical trials

Astellas’ eyes filings for menopause drug fezolinetant after ph3 win

Pharmaforum

Mon, 03/7/22 - 10:07 am

clinical trials

March-in campaign on Pfizer's prostate cancer med Xtandi gets congressional backing. Will it matter?

Fierce Pharma

Tue, 02/22/22 - 11:17 pm

prostate cancer

Trial win sets up new use for Astellas, Seagen’s Padcev in bladder cancer

Pharmaforum

Mon, 02/14/22 - 11:44 pm

clinical trials

Astellas becomes latest Dyno gene therapy partner with $1.6B biobucks pact to join Roche, Novartis, Sarepta

Fierce Biotech

Wed, 12/1/21 - 11:51 pm

Dyno Therapeutics

ESMO: Pfizer, Astellas' latest Xtandi survival data may shore up prostate cancer lead over J&J

Fierce Pharma

Sat, 09/18/21 - 08:26 pm

prostate cancer

clinical trials

Astellas readies roxadustat for launch

EP Vantage

Wed, 09/15/21 - 10:37 am

Astellas reports fourth death in halted gene therapy trial

Pharmaforum

Tue, 09/14/21 - 10:59 am

clinical trials

X-linked myotubular myopathy

More trouble for Astellas as AT132 gene therapy trial is halted again

Pharmaforum

Wed, 09/1/21 - 11:02 am

clinical trials

X-linked myotubular myopathy

After FDA snub, EMA backs FibroGen, Astellas’ roxadustat

Pharmaforum

Fri, 08/20/21 - 10:51 am

chronic kidney disease

FDA Approvals Roundup: Kerendia, Padcev, Darzalex Faspro

RAPS.org

Thu, 07/15/21 - 12:34 pm

Teva Pharmaceutical

ArmonAir RespiClick

Darzalex Faspro

Pneumococcal Vaccine Snags Breakthrough Therapy Designation

BioSpace

Tue, 07/13/21 - 11:29 pm

pneumococcal disease

breakthrough therapy

Seagen, Astellas' Padcev snares full approval and expands into second-line treatment on path to blockbuster land

Fierce Pharma

Sat, 07/10/21 - 12:00 am

The big approvals still on the cards for 2021

EP Vantage

Thu, 06/17/21 - 11:00 am

Ascendis Pharma

Axsome Therapeutics

#ASCO21: Ahead of August PDUFA date, Astellas and Seagen sweeten Padcev pitch with new data

Endpoints

Thu, 05/20/21 - 12:16 pm

urothelial cancer

Astellas quietly cuts Cytokinetics R&D pact as $450M-plus in biobucks goes up in smoke

Fierce Biotech

Mon, 05/3/21 - 10:51 am

Astellas takes $540M impairment charge over Audentes' gene therapy trial hold

Fierce Biotech

Tue, 04/27/21 - 10:47 am

Astellas innovation awards offer up ideas to ease cancer patients' pandemic burdens

Fierce Pharma

Tue, 04/20/21 - 07:36 pm

Seagen gets August PDUFA for Padcev expansions

Endpoints

Mon, 04/19/21 - 10:25 pm

Pages